SEP 27, 2016 2:22 PM PDT

Machine Outperforms Doctors at Diagnosing Brain Cancer

WRITTEN BY: Xuan Pham
“Come in, Mr. Smith. The computer is ready for your diagnosis now.” This could conceivably be in store for brain cancer patients in the future, as a new computer program shows nearly twice the accuracy of doctors at diagnosing the tumors.
 
Computer training and machine learning has come a long ways – machines have beat humans in Jeopardy!, chess, even Go. In August 2016, machine learning even helped to rekindle seemingly deadened nerves, giving paraplegics limb sensations they hadn’t felt in years. Now, Case Western Reserve researchers say their computer program can tell whether abnormal MRI scans are indicative of dead tissues (radiation necrosis) or the recurrence of brain cancer. And, impressively, the program can do this better than trained neuroradiologists.

MRI scans of patients with radiation necrosis (above) and cancer recurrence (below) are shown in the left column. | Image: Tiwari Lab
 
"One of the biggest challenges with the evaluation of brain tumor treatment is distinguishing between the confounding effects of radiation and cancer recurrence," said Pallavi Tiwari, assistant professor of biomedical engineering at Case Western Reserve and leader of the study. "On an MRI, they look very similar."
 
To better distinguish between radiation necrosis and cancer recurrence, the team trained a computer to read radiomic features from an image scan. These features include textures and densities that can’t be gleaned with the naked eye.
 
"What the algorithms see that the radiologists don't are the subtle differences in quantitative measurements of tumor heterogeneity and breakdown in microarchitecture on MRI, which are higher for tumor recurrence," said Tiwari.
 

The algorithm also takes into account the edge space of a mass. This can reveal important information about the identity of the mass. "If the edges all point to the same direction, the architecture is preserved," said Anant Madabhushi, professor at Case Western who is co-author on the study. "If they point in different directions, the architecture is disrupted -- the entropy, or disorder, and heterogeneity are higher."
 
In a head-to-head test, the team gave 15 MRI scans to 2 physicians and compared the results to that from the computer algorithm. The algorithm was able to correctly diagnose more cases (12 total) than either of the physicians (7 and 8 cases each).
 
While it may still be unreasonable to solely rely on a computer algorithm to read brain cancer scans, the team hopes this tool will augment the accuracy of diagnoses for patients. Importantly, the right diagnosis can eliminate unnecessary biopsies and other procedures that are both extremely stressful and costly. 

Additional source: Case Western Reserve University
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 27, 2020
Clinical & Molecular DX
A Super Sensitive Alzheimer's Test Powered by Nanozymes
OCT 27, 2020
A Super Sensitive Alzheimer's Test Powered by Nanozymes
  Simple tasks are now uphill struggles, social situations aren’t fun, and the car keys are missing again. By ...
NOV 03, 2020
Clinical & Molecular DX
"Hello? It's Me, the Coronavirus."
NOV 03, 2020
"Hello? It's Me, the Coronavirus."
Researchers at MIT have discovered an unlikely way of discerning those with COVID-19 from healthy individuals — si ...
DEC 15, 2020
Clinical & Molecular DX
Who Should Get the COVID Vaccine First?
DEC 15, 2020
Who Should Get the COVID Vaccine First?
Drug developers’ frantic hunt for vaccines against SARS-CoV-2 has finally begun to bear fruit, with several vaccin ...
JAN 07, 2021
Clinical & Molecular DX
Breath of Life: Nighttime Respiratory Rates Identify Which Heart Patients Need Surgery
JAN 07, 2021
Breath of Life: Nighttime Respiratory Rates Identify Which Heart Patients Need Surgery
Cardiovascular disease is the leading cause of death worldwide, taking nearly 18 million lives every year. Of these card ...
JAN 27, 2021
Clinical & Molecular DX
No Pain, All the Diagnostic Gain
JAN 27, 2021
No Pain, All the Diagnostic Gain
A recent study published in Nature Biomedical Engineering describes new microneedle patch technology that takes the &ldq ...
MAR 04, 2021
Clinical & Molecular DX
Is the Cancer Treatment Working? Liquid Biopsies Provide Answers.
MAR 04, 2021
Is the Cancer Treatment Working? Liquid Biopsies Provide Answers.
A newly-developed tool could help physicians monitor the performance of colorectal cancer therapies simply by examining ...
Loading Comments...